Interleukin-15 protects from lethal apoptosis in vivo

[1]  R. Paus,et al.  Differential regulation of human T lymphoblast functions by IL-2 and IL-15. , 1997, Cytokine.

[2]  A. Ashkenazi,et al.  Immunoadhesins as research tools and therapeutic agents. , 1997, Current opinion in immunology.

[3]  T. Pohl,et al.  Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms. , 1997, Journal of immunology.

[4]  T. Waldmann,et al.  IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. , 1996, Immunity.

[5]  D. Scott,et al.  T cells commit suicide, but B cells are murdered! , 1996, Journal of immunology.

[6]  T. Pohl,et al.  Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in mice. , 1996, The Journal of clinical investigation.

[7]  John Calvin Reed,et al.  Interleukin‐2 receptor common γ‐chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: Selective induction of anti‐apoptotic (bcl‐2, bcl‐xL) but not pro‐apoptotic (bax, bcl‐xS) gene expression , 1996, European journal of immunology.

[8]  S. Nagata,et al.  Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells. , 1995, International immunology.

[9]  F. Alt,et al.  Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.

[10]  R. Dubose,et al.  Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor. , 1995, The EMBO journal.

[11]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[12]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[13]  P. Krammer,et al.  Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) , 1995, Nature.

[14]  S. Nagata,et al.  Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody , 1995, The Journal of experimental medicine.

[15]  D. Cosman,et al.  Utilization of the beta and gamma chains of the IL‐2 receptor by the novel cytokine IL‐15. , 1994, The EMBO journal.

[16]  V. Fung,et al.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. , 1994, Science.

[17]  S. Nagata,et al.  Lethal effect of the anti-Fas antibody in mice , 1993, Nature.

[18]  O. Janssen,et al.  Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. , 1993, Journal of immunology.

[19]  T. Taniguchi,et al.  The IL-2 IL-2 receptor system: A current overview , 1993, Cell.

[20]  M. Lenardo lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis , 1991, Nature.

[21]  Gwyn T. Williams,et al.  Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures , 1989, Nature.

[22]  J. Cohen,et al.  Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. , 1984, Journal of immunology.

[23]  E. White,et al.  Life, death, and the pursuit of apoptosis. , 1996, Genes & development.

[24]  B. Viollet,et al.  Bcl–2 protects from lethal hepatic apoptosis induced by an ant–Fas antibody in mice , 1996, Nature Medicine.

[25]  E. Coligan Current protocols in immunology , 1991 .